2022
Bayesian Model Averaging to Account for Model Uncertainty in Estimates of a Vaccine’s Effectiveness
Oliveira CR, Shapiro ED, Weinberger DM. Bayesian Model Averaging to Account for Model Uncertainty in Estimates of a Vaccine’s Effectiveness. Clinical Epidemiology 2022, 14: 1167-1175. PMID: 36281232, PMCID: PMC9587703, DOI: 10.2147/clep.s378039.Peer-Reviewed Original ResearchVaccine effectiveness studiesCase-control studyConfidence intervalsModel uncertaintyYears of ageBayesian model averaging frameworkResidents of ConnecticutModel selection methodsLyme vaccineVaccine effectivenessVE estimatesPotential confoundersImmunization historyHealthy controlsMedical recordsMultivariable modelingBayesian model averagingPerformance of BMANew vaccinesReal-world settingEffectiveness studiesLyme diseaseBMA frameworkParameter estimationControl of confounding
2021
Clinical Effectiveness of Lyme Vaccine: A Matched Case–Control Study
Oliveira CR, Massad C, Shapiro ED, Vazquez M. Clinical Effectiveness of Lyme Vaccine: A Matched Case–Control Study. Open Forum Infectious Diseases 2021, 8: ofab142. PMID: 34409119, PMCID: PMC8364756, DOI: 10.1093/ofid/ofab142.Peer-Reviewed Original Research
2015
Update on persistent symptoms associated with Lyme disease
Oliveira CR, Shapiro ED. Update on persistent symptoms associated with Lyme disease. Current Opinion In Pediatrics 2015, 27: 100-104. PMID: 25490690, PMCID: PMC4417349, DOI: 10.1097/mop.0000000000000167.Commentaries, Editorials and LettersConceptsViable B. burgdorferiLyme diseasePersistent symptomsB. burgdorferiConventional treatmentAntimicrobial treatmentCommon vector-borne illnessPersistent active infectionPersistent nonspecific symptomsVector-borne illnessConventional antimicrobial treatmentPersistent arthritisChronic symptomsNonspecific symptomsOngoing symptomsErythema migransActive infectionPersistent infectionRecent studiesSlow clearancePatientsSymptomsDiseaseNonviable organismsInfection